Position in MYGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$615,440
+$333,452 QoQ
Shares Held
107,783
+72.0% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#67
of 196 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026State of Wyoming holds $8,865,809 across 22 Diagnostics & Research names. MYGN ranks #3 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
22,228 | $3,861,225 | |
| 2 | SHC |
Sotera Health Co
|
56,651 | $1,005,555 | |
| 3 | MYGN |
Myriad Genetics Inc
This page
|
107,783 | $615,440 | |
| 4 | GH |
Guardant Health, Inc.
|
2,620 | $393,078 | |
| 5 | VCYT |
Veracyte, Inc.
|
6,192 | $363,656 | |
| 6 | NEO |
Neogenomics Inc
|
19,811 | $289,042 | |
| 7 | GRAL |
GRAIL, Inc.
|
3,982 | $271,851 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,196 | $271,240 |
All Filings in MYGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $615,440 | 107,783 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $281,988 | 62,664 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $164,463 | 26,742 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $261,610 | 36,184 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $163,399 | 30,772 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $76,645 | 8,641 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $47,957 | 3,498 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $106,684 | 3,895 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $37,562 | 1,617 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $14,608 | 804 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||